C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said ...
Vave Health has launched Universal Wireless Probe, a hand-held device aimed at improving diagnostics in various clinical ...
Helius’ new subsidiary, Revelation Neuro, will target a non-implantable form of BCI. Helius Medical Technologies is muscling ...
Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...
University of Turku researchers have developed sensors from single-wall carbon nanotubes for continuous health monitoring.
The FDA has approved Valcare Medical’s IDE application, allowing it to begin an EFS of Amend Trans-Septal System.
The US Food and Drug Administration (FDA) has cleared Perfuze’s Zipline access catheter for acute ischemic stroke (AIS) ...
Proteomics International Laboratories has launched the PromarkerD diabetic kidney disease (DKD) predictive test in Australia.
MicroTransponder has received $65m in Series F funds to enhance its stroke care offerings with the Vivistim Paired VNS System ...
A study has found that nearly a third of medical device AEs were reported by manufacturers later than FDA's required 30-day ...
Renal denervation offers a potentially transformative and minimally invasive option for treating hypertension. With this ...
Series A funding round led by Angelini Ventures’, the investment arm of Italian industrial group Angelini Industries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results